| Literature DB >> 25453194 |
Eugene H Chung1, Kimberly D Guise2.
Abstract
We assessed the feasibility of AliveCor tracings for QTC assessment in patients receiving dofetilide. Five patients with persistent AF underwent the two-handed measurement (mimicks Lead I). On the ECG, Lead I or II was used. There was no significant difference between the AliveCor-QTC and ECG-QTC (all ±20 msec). The AliveCor device can be used to monitor the QTC in these patients.Entities:
Keywords: AliveCor; Atrial fibrillation; ECG; QT interval; QTC
Mesh:
Substances:
Year: 2014 PMID: 25453194 DOI: 10.1016/j.jelectrocard.2014.10.005
Source DB: PubMed Journal: J Electrocardiol ISSN: 0022-0736 Impact factor: 1.438